以持续性眩晕为表现的水平半规管良性阵发性位置性眩晕的诊治

目的　探讨以持续性眩晕为表现的良性阵发性位置性眩晕（benign paroxysmal positional vertigo,BPPV）患者的诊治。方法　回顾性分析2例以持续性眩晕为表现的BPPV患者的临床资料。结果　此2例患者在坐位及平躺位见方向向患侧的水平自发持续性眼震,甩头试验健侧阳性,平卧侧头试验双侧均诱发出水平离地性眼震,平躺后头部向患侧连续转360°时分别出现2个眼震消失点和2个眼震最强点,给予手法复位后患者眩晕症状缓解。结论　水平半规管BPPV患者偶可表现为持续性眩晕发作,其病因为壶腹嵴帽耳石症,临床表现与耳石重力因素和水平半规管空间位置相关。     

Dix-Hallpike诱发试验双侧阳性的良性阵发性位置性眩晕的临床分析

目的探讨良性阵发性位置性眩晕(Benign Paroxysmal Positional Vertigo,BPPV)患者Dix-Hallpike诱发试验双侧阳性的眼震特点和诊治策略。方法回顾性分析2018年1月至2019年12月就诊于安徽医科大学第二附属医院耳鼻喉科的BPPV患者的诊治过程。结果 Dix-Hallpike诱发试验,阳性患者150例,其中双侧阳性患者14例,2例双侧可见扭转、向上、向地性眼震,进一步行平躺试验为垂直向上性眼震,分次给予双侧改良Epley法复位后双侧眼震均消失;12例患侧为扭转、向上、向地性眼震,健侧为扭转、向上、离地性眼震者,给予患侧改良Epley法复位后双侧眼震均消失。结论除了双侧后半规管BPPV,部分单侧后半规管BPPV患者行Dix-Hallpike诱发试验也可表现为双侧阳性结果,临床诊治应注意眼震方向形式的差别。     

甲磺酸倍他司汀对良性阵发性位置性眩晕位置试验眼震的影响CSCD

目的探讨甲磺酸倍他司汀对良性阵发性位置性眩晕(BPPV)位置试验眼震的影响。方法2022年1~6月就诊的头晕患者并且予BPPV位置试验检查,其中61例检查前24h内仅口服过甲磺酸倍他司汀治疗,199例检查前24h内口服其他药物或者多种药物联合治疗。观察其停药前、后BPPV位置试验眼震变化情况:检查前24h内有用药史者,先予第1次BPPV位置试验,记录眼震情况;若第1次位置试验为阴性,嘱其停药24h后再予第2次BPPV位置试验,记录眼震情况;若第1次位置试验为阳性,予手法复位治疗,1h后复查,若复位效果欠佳,嘱其停药24h后再予第2次BPPV位置试验,记录眼震情况。位置试验眼震均通过视频眼罩观察。结果检查前24h内仅口服过甲磺酸倍他司汀的患者中,第1次BPPV位置试验眼震阳性者占16.39%(10/61),停药24h后第2次BPPV位置试验眼震阳性者占49.02%(25/51),停药前、后BPPV位置试验眼震阳性率有显著统计学差异(x2=8.89,P=0.003)。第1次位置试验眼震阳性者中,有5例(50%)在停药24h后第2次位置试验中眼震强弱程度发生变化,导致定位患侧半规管发生变化:2例左水平半规管BPPV修正为右水平半规管BPPV;1例左水平半规管帽型BPPV修正为右水平半规管帽型BPPV;2例水平半规管帽型BPPV,从第1次位置试验无法根据眼震强弱程度辨别患侧,到第2次位置试验可以根据眼震强弱程度明确患侧。结论甲磺酸倍他司汀对BPPV位置试验的精确性有一定影响,主要表现为抑制患者发病时原有的眼震,建议停药24h后再做位置试验,有助于BPPV精准诊疗。     

水平半规管良性阵发性位置性眩晕的诊断

目的探讨水平半规管良性阵发性位置性眩晕（BPPV）的诊断。方法自2003年1月至2006年9月，本眩晕中心共确诊为水平半规管BPPV（HSC BPPV）患者46例。诊断依据为典型的病史及用红外视频眼震电图仪记录患者在Dix—Hallpike试验和滚转试验中的眼震结果，并排除其他疾病。研究HSC BPPV的眼震特点。结果441例诊断为BPPV患者中，46例（10．43％）为水平半规管BPPV。其中38例（82．61％）为单侧病变，5例（10．87％）患者合并同侧后半规管病变，3例（6．52％）为双侧病变。35例患者通过两种试验诱发出水平眼震，11例患者仅通过滚转试验诱发出水平眼震。25例患者眼震方向向地，13例患者眼震方向背地，3例患者眼震方向不固定，5例患者各种手法诱发出同一方向的眼震。29例患者在双侧手法中出现眼震，17例患者在一侧手法中出现眼震。结论HSC BPPV眼震为完全水平性且多为快相向地。通常受累耳在双侧手法中均可出现眼震，以向患侧为重。一侧水平半规管和后半规管可同时受累。滚转试验在HSC BPPV检查中比Dix—Hallpike试验更加敏感。Dix—Hallpike试验结合滚转试验可使更多的HSCBPPV患者得到确诊．     

红外视频采集仪记录BPPV患者眼震的结果分析

目的探讨用红外视频眼动采集仪(CHARTR VNG)观察记录良性阵发性位置性眩晕(benign paroxys-mal positional vertigo,BPPV)患者的眼震特点。方法用红外视频采集仪详细记录78例BPPV患者在Dix-Hallpike试验及滚转试验中的眼震变化。结果40例(51.28%)为一侧后半规管病变;13例(16.67%)为一侧水平半规管病变;6例(7.7%)为一侧上半规管病变;19例(24.36%)出现多发位置性眼震,其中6例为双侧后半规管病变,2例双侧上半规管病变,3例为双侧水平半规管病变,8例患者在不同头位下出现眼震,提示混合半规管病变。结论红外视频眼动采集仪可以更直观地观察眼动变化,对诊断BPPV受累半规管提供可靠依据,特别是对非典型位置性的眼震,能更好的提示良性阵发性位置性眩晕患者非典型位置性的眼震发生率,包括水平半规管、上半规管病变和多个半规管联合病变。患者的治疗可以根据不同的受累半规管采取不同方法。     

水平半规管良性阵发性位置性眩晕患者眼震参数客观特征

目的 探讨水平半规管良性阵发性位置性眩晕(BPPV)眼震的方向、强度、时间等参数的客观特征及机制.方法 水平半规管BPPV患者233例,其中水平半规管管石症(horizontal semicircular canalithasis,HSC-Can) 179例,水平半规管壶腹嵴顶结石症(horizontal semicircular canal cupulolithiasis,HSC-Cup)54例.应用视频眼震图仪分别记录滚转试验诱发眼震,比较各个试验头位的眼震方向、强度、时间等参数特点.采用SPSS17.0统计软件进行数据处理.结果 水平半规管BPPV患者滚转试验在左侧、右侧转头位均可诱发出水平性眼震.HSC-Can诱发眼震方向与转头方向相同,向患侧和健侧转头位诱发眼震的潜伏期(-x±s,下同)为(1.922±1.501)s和(1.447±0.855)s,持续时间为(25.620±10.409)s和(22.110±10.931)s,强度为(56.441±33.168)°/s和(24.239±13.892)°/s,向患侧转头诱发眼震的潜伏期、持续时间及强度均大于健侧,差异均具有统计学意义(t值分别为3.715、15.219和4.070,P值均＜0.01),其中眼震强度之比约为2∶1.HSC-Cup诱发眼震方向与转头方向相反,向健侧转头诱发眼震的强度明显大于向患侧转头,其强度之比约为2∶1,差异具有统计学意义(t=-7.634,P＜0.01);而向健侧和向患侧转头诱发眼震的潜伏期,差异则无统计学意义(t=1.670,P=0.101).HSC-Can滚转试验中向患侧转头诱发眼震的潜伏期、强度均大于HSC-Cup向健侧转头,但差异无统计学意义(t值分别为1.554和0.305,P值均＞0.05).结论 水平半规管BPPV患者滚转试验向左右侧转头诱发眼震的强度均遵循Ewald定律,强弱之比约为2∶1;潜伏期、持续时间及强度等眼震图参数可作为BPPV的客观诊断指标.     

良性阵发性位置性眩晕的眼震图研究

目的:探讨视频眼震图(VNG)在良性阵发性位置性眩晕(BPPV)中的应用价值。方法:回顾126例BPPV患者的VNG资料,分析总结各型BPPV在Dix-Hallpike和滚转试验中VNG上的眼震特点。结果:126例BPPV患者中,后半规管BPPV(PSC-BPPV)98例(77.8%),水平半规管BPPV(HSC-BPPV)17例(13.5%),前半规管BPPV(ASC-BPPV)5例(3.9%),混合型BPPV6例(4.8%);28例PSC-BPPV记录到反转相眼震。VNG上显示PSC和ASC管石症Dix-Hallpike悬头位垂直相眼震分别向上、向下,水平相眼震均向对侧,回到坐位时眼震反向。HSC-BPPV滚转试验向两侧转头均可诱发出眼震,眼震与转头方向相同时,可判断为HSC管石症,以能够诱发较强眼震的转头侧为患侧;眼震与转头方向相反时,则为HSC嵴顶结石症,以能够诱发较弱眼震的转头侧为患侧。结论:VNG能够客观地记录BPPV患者的眼震情况,准确判断耳石所在的半规管,并且保存了眼震数据资料,可以进一步指导临床实践,值得推广。     

水平半规管良性阵发性位置性眩晕的临床特点及疗效分析

目的 探讨水平半规管良性阵发性位置性眩晕(benign paroxysmal positional vertigo,BPPV)的临床特点.方法 回顾性分析56例水平半规管BPPV患者的临床表现及眼震电图特征,通过体位试验确诊BPPV后,水平向地性眼震者以Barbecue翻滚法复位治疗,水平背地性眼震者经左右侧头训练后再同法复位,并限制体位.结果 56例患者中,平卧侧头试验见水平向地性眼震者41例,潜伏期为2.5±1.3s,其中5例患者无明显潜伏期,眼震持续时间22.9±16.4s,2例持续时间≥60 s;诱发出水平背地性眼震者15例,潜伏期为3.7±3.1s,眼震持续时间67.2±17.7s,其中2例持续时间≤60 s.41例水平向地性眼震者中39例1次复位成功,首次复位治疗成功率为95.12％(39/41),其中2例眼震持续时间＞60 s的患者均一次复位成功;有2例复位不成功.15例水平背地性眼震患者中,2例在首次左右侧头训练时即见眼震转化为水平向地,3例在2～4次随访时转化为水平向地;眼震转化后再行平卧侧头试验表现为,转向起初眼震为水平背地较弱侧时,其水平向地性眼震更明显,且眼震速度明显增快、潜伏期明显缩短.结论 在水平半规管BPPV患者的复位治疗过程中,翻滚复位法结合左右侧头训练及体位限制有助于复位成功.     

水平半规管良性阵发性位置性眩晕的临床特点

目的 探讨水平半规管良性阵发性位置性眩晕(benign paroxysmal positional vertigo,BPPV)的临床特点.方法 回顾性分析2003年8月至2010年12月诊治的239例水平半规管BPPV患者的临床表现.结果 水平半规管BPPV占同期全部BPPV患者的25.7％(239/931).平卧侧头试验见水平向地性眼震者197例,眼震的平均潜伏期为(0.88±0.72)s,持续时间(26.36±19.71)s;水平离地性眼震者42例,平均潜伏期(2.69±1.83)s,持续时间(53.48±43.12)s;其中39例眼震表现为水平略带扭转向上而非纯水平,占16.3％(39/239).离地组眼震潜伏期明显长于向地组(t=-6.33,P＜0.001),眼震持续时间亦明显长于向地组(t=-3.99,P＜0.001).水平向地性眼震者予以Barbecue翻滚法治疗,192例经(1.6±0.8)个循环复位成功;水平离地性眼震者经左右侧头训练后,40例眼震转化为向地性,经(1.9±0.8)个循环后复位成功.结论 水平半规管BPPV占同期BPPV的比例较预期高.水平向地性眼震患者可直接给予Barbecue翻滚法治疗,水平离地性眼震患者应先行左右侧头训练,再给予Barbecue翻滚法复位.     

位置性眩晕和向上性、双向性眼震

良性阵发性位置性眩晕（BPPV）是最常见的一种位置性眩晕，可能因后半规管（PSC）壶腹顶耳石或半规管耳石脱落引起。典型的PSC－BPPV眼震电图特点是巾一大的上跳性垂直眼震和一小的向上的水平性服震构成的非共轭性眼震。潜伏期短呈易疲劳性。阵发性位置性水平眼震同时伴有与BPPV相同的症状，可在有位置性眩晕的小部分病人中观察到。这种眼晨可能是外半规管BPPV的一种变型。该作者评定了9例在仰卧、头转向左或右均出现向上性眼震的BPPV患者。病人均经采集病史和详细的耳神经学检查。位置试验按Dix和HallPike法进行，病人均进行临…     

Cochlear implantation in Mondini’s deformity: could the straight electrode array with length of 31 mm be fully inserted?

Conclusions: The straight electrode array with length of 31?mm can be fully inserted using round window insertion in cochlear implantation with Mondini’s deformity. It is a safe and effective process, but also a challenging task of the full implantation in children with Mondini’s deformity.

Objective: The aim of this study is to discuss whether the straight electrode array with a length of 31?mm could be fully inserted in cochlear implantation with Mondini’s deformity.

Methods: A chart review of 30 patients undergoing cochlear implantation with Mondini’s deformity using the electrode array with length of 31?mm was undertaken from January 2012 and December 2015 in Anhui Provincial Hospital.

Results: Full insertion of the straight electrode array with length of 31?mm were performed successfully in all patients with Mondini’s deformity using round window insertion. Resistance was not encountered while introducing the electrodes. Ten of 30 patients had cerebrospinal fluid drainage during cochlear implantation. Cerebrospinal fluid drainage was controlled with small pieces of temporalis fascia packing round window in all patients. Intra-operative neural response telemetry was performed in all patients, and results were good. The result of X-ray showed proper placement of the cochlear implant electrode array. During surgery, no patients had experienced any immediate or delayed post-operative complications such as wound infection, intracranial complication, extrusion, or migration of the implant during an average follow-up period of 6–36 months.     

1448例人工耳蜗植入手术中疑难问题的总结

目的通过对1448例人工耳蜗植入手术的总结,讨论人工耳蜗植入术中疑难问题,为提高人工耳蜗植入手术的成功率提供参考。方法1448例人工耳蜗植入手术病例资料来源于1998年1月～2009年3月。术前信息年龄8．5个月～51．2岁,平均年龄为4．57。全部为双耳重度和极重度感音神经性聋,其中语前聋患者1430例、成人语后聋患者18例。术前进行常规检查包括：①听力学检查、影像学检查、小儿肢体智力发育评估。②全麻常规检查。手术方法：①按常规面神经隐窝入路自耳蜗底转鼓阶植入耳蜗电极。②自乳突入路从耳蜗与前庭共同腔后下植入耳蜗电极。③在开放式乳突腔内埋藏电极线后仍于圆窗入路植入耳蜗电极。手术疑难判断方法：①无法按常规面隐窝入路手术者。②由于乙状窦、天盖、外耳道壁等解剖问题不能顺利完成乳突轮廓化者。③由干面神经、鼓索神经、外耳道骨壁的解剖问题使开放面隐窝的空间狭小导致暴露圆窗困难者。④耳蜗或圆窗等骨化或畸形等问题不能按常规自圆窗口部顺利植入耳蜗电极者。结果①手术成功率：1448例人工耳蜗植入手术均～期成功,成功率为100％。②术中疑难问题：术中疑难问题共241例（耳）,占16．64％,其中非常规手术入路10例,乙状窦前移影响手术入路4例,面神经垂直部高位并前移使与鼓素神经或外耳道壁的距离狭小影响圆窗的暴露179例,耳蜗底转骨化影响打开耳蜗鼓阶23例,圆窗骨化无法以圆窗为标记打开耳蜗鼓阶15例,耳蜗海绵状改变判断鼓阶正确位置困难5例,耳蜗与内听道共同腔耳蜗电极在共同腔内正确摆放困难5例。结论对1448例人工耳蜗植入手术总结体会认为,人工耳蜗植入手术中的疑难问题主要表现为：①面神经垂直部过度前移影响圆窗的暴露。②耳蜗骨化或海绵状改变影响开放耳蜗     

中耳乳突炎性病变的人工耳蜗植入术

目的探索双侧重度感音神经性聋合并中耳乳突炎性病变人工耳蜗植入手术方法.方法 29例不同类型中耳乳突炎患者行人工耳蜗植入手术,根据炎症病变程度采用Ⅰ期手术26例,分期手术3例.非化脓性及慢性中耳炎静止期者,行完壁式乳突根治术,清除病灶,保留骨性外耳道,同期行人工耳蜗植入;化脓性中耳炎者,行完壁式或开放式乳突根治术,清除病灶保留骨性外耳道或重建外耳道后上壁,获得干耳后,Ⅱ期行人工耳蜗植入.结果 29例中耳乳突不同炎症病变患者经Ⅰ期或分期手术,人工耳蜗电极均顺利植入.随访2～8年,无炎症病变复发,开机后人工耳蜗工作正常,无电极裸露、脱出.结论中耳乳突炎性病变经正确的手术措施干预后,可行人工耳蜗植入.强调依据病变程度和范围个性化处理.     

Temporal bone results and hearing preservation with a new straight electrode

Due to improved technology, cochlear implant (CI) candidacy has been widened towards patients with usable residual hearing in the low frequency range. These patients might benefit from additional acoustic amplification provided that residual hearing can be preserved with cochlear implantation. To provide a high probability of hearing preservation, a new electrode array was designed and developed at the Medizinische Hochschule Hannover. This 'Hybrid-L' electrode array has 22 electrodes spread over 15 mm with an overall insertion depth of 16 mm. The straight electrode with modiolus facing contacts is designed for a round window insertion. It shall provide the full range of the currently most advanced Nucleus CI system. A temporal bone study demonstrated the favorable insertion characteristics and minimized trauma to intracochlear structures. Compared to standard CI electrodes especially no basilar membrane perforation could be found. So far, 4 patients have been implanted and residual hearing could be preserved. One patient was fitted and showed a marked additional benefit from the electroacoustic stimulation compared to either acoustic or electrical stimulation alone. These results are very encouraging towards a concept of reliable hearing preservation with cochlear implantation.     

Effects of round window dexamethasone on residual hearing in a Guinea pig model of cochlear implantation

To study electric acoustic stimulation, we have developed a model of guinea pig cochlear implantation via a cochleostomy. Thirty minutes prior to implantation, a hyaluronic acid/carboxymethylcellulose bead, loaded with either dexamethasone or normal saline, was placed upon the round window membrane. Animals that did not receive beads acted as controls. Pure-tone auditory brainstem response thresholds were estimated before and after electrode insertion, and 1 and 4 weeks later. Selected cochlear histology was performed. RESULTS: Dexamethasone could be detected in the cochlea for 24 h after cochlear implantation. Thresholds were elevated across frequencies in all animals immediately after surgery. These thresholds recovered completely at and below 2 kHz, and partially at higher frequencies by 1 week after implantation. At 32 kHz, but not the lower frequencies, the presence of dexamethasone had a significant protective effect upon hearing, which increased in magnitude over time. The protection was greatest in difficult implantations where an intractable resistance to electrode insertion was met. There was a persistent foreign body reaction at the site of implantation of saline-treated implanted ears but not in the dexamethasone-treated implanted ears. CONCLUSION: Short-term preoperative delivery of dexamethasone through the round window can protect residual hearing during cochlear implantation, especially during technically difficult surgery.     

Electrode array misplacement into the superior semicircular canal: As a rare complication of cochlear implantation

Objective

To report electrode array misplacement into the superior semicircular canal occurring as an rare complication of cochlear implantation through round window insertion, and to explore the causative association between electrode array misplacement and cochlear implantation surgical techniques.

Methods

A chart review of the electrode array misplacement into the superior semicircular canal and their management in 695 patients undergoing cochlear implantation was undertaken from January 2003 and January 2014 in Anhui Provincial Hospital.

Results

There were two children of electrode array misplacement into the superior semicircular canal complication, and the rate was 0.28%.

Conclusions

Electrode array misplacement into the superior semicircular canal associated with cochlear implantation is rare. Surgeons should be aware of that the smaller round window maybe the reason of electrode array misplacement through round window insertion. Intra-operative neural response telemetry and X-ray can alert the surgeon the problem with the array's misplacement, which can be identified by postoperative CT.     

Cochlear implantation in healthy and otitis-prone children: a prospective study

OBJECTIVE: To evaluate and compare the timing of surgery, intraoperative findings, and otitis media-related outcome of cochlear implantation in children who are otitis-prone with their counterparts who are not otitis-prone. STUDY DESIGN: Prospective. METHODS: Children referred for cochlear implantation were assigned to a non-otitis-prone group (group A: normal otoscopy on their first visit after referral) or an otitis-prone group (group B: current or a recent history of otitis media at referral). Group B patients were managed using a structured protocol aimed at preimplantation otitis media control. The study reviewed pre-, intra-, and postoperative data. RESULTS: Of the 18 children studied, 8 were assigned to group A (mean age at referral, 40.6 mo) and 10 to group B (mean age at referral, 31.6 mo). For otitis media control, all otitis-prone children underwent ventilating tube insertion (various numbers of procedures before implantation). Only one otitis-prone child required cortical mastoidectomy also. Time from referral to implantation was similar in the two groups (mean, 6.6 mo). High-resolution computed tomography data showed mastoid pneumatization to be significantly smaller in the otitis-prone group, but the facial recess was not smaller in this group. During implantation, 10 children had inflamed middle ear mucosa. Seven of these belonged to group B. All of these seven children had a round window niche obliterated by the inflamed mucosa, which had to be removed for round window membrane identification. After implantation, only one child had drainage through the ventilating tube for more than 1 week. Two children in group B developed otitis media (1 year postimplantation) that was overcome within 1 week. There were no otitis media-related complications. CONCLUSIONS: If a structured protocol is used for the control of otitis media before cochlear implantation, otitis media should not require a delay in implantation. In otitis media-prone children, the round window niche is often obscured by inflamed mucosa. Its removal is mandatory for identification of the round window membrane. After cochlear implantation, otitis media is not a frequent occurrence.     

Cochlear implantation without mastoidectomy: the pericanal electrode insertion technique

OBJECTIVE: A new minimally invasive cochlear implantation method with direct electrode insertion through the external auditory canal (EAC) is presented. MATERIAL AND METHODS: Surgery begins with a retroauricular skin incision. The bony surface of the mastoid plane behind the ear is dissected free and the skin of the EAC is elevated together with the posterior part of the tympanic membrane. Cochleostomy is performed through the EAC with a microdrill anterior to the round window. A rim is drilled into the postero-superior region of the bony EAC immediately above the incus towards the outer border of the EAC and connected to the retroauricular surface by a short tunnel. The implant device is placed in the usual retroauricular area. The electrode is inserted through the tunnel and rim into the tympanic cavity and pushed into the cochleostomy hole. The electrode is immobilized in the rim using glass ionomer cement and covered with bone dust. After placement of the ground electrode, the retroauricular incision is closed. The tympano-meatal flap is replaced and a dressing is put into the EAC. RESULTS: The new method has been applied thus far in 15 adults and pre-adolescent deaf patients (8 females, 7 males). A MED-EL Combi 40 + device was used in 14 patients and a Nucleus CI24M in 1. Pericanal electrode insertion was easy, with insertion depths into the cochlea of > or = 30 mm with the MED-EL and of 20 mm with the Nucleus device. There were no surgical complications, infections or electrode extrusions during postoperative observation periods ranging from 6 months to > 2 years. The functional results were comparable to those obtained with cochlear implantation via mastoidectomy. The pericanal electrode insertion technique has several advantages, the most important being that the danger of facial nerve damage is minimized and that the operating time is reduced by up to 50%. CONCLUSION: Cochlear implantation with pericanal electrode insertion is a simple, fast and particularly safe option which may replace the classical transmastoidal cochlear implantation method in adults and older children.     

Cochlear Implantation Without Mastoidectomy: The Pericanal Electrode Insertion Technique

Objective - A new minimally invasive cochlear implantation method with direct electrode insertion through the external auditory canal (EAC) is presented. Material and methods - Surgery begins with a retroauricular skin incision. The bony surface of the mastoid plane behind the ear is dissected free and the skin of the EAC is elevated together with the posterior part of the tympanic membrane. Cochleostomy is performed through the EAC with a microdrill anterior to the round window. A rim is drilled into the postero-superior region of the bony EAC immediately above the incus towards the outer border of the EAC and connected to the retroauricular surface by a short tunnel. The implant device is placed in the usual retroauricular area. The electrode is inserted through the tunnel and rim into the tympanic cavity and pushed into the cochleostomy hole. The electrode is immobilized in the rim using glass ionomer cement and covered with bone dust. After placement of the ground electrode, the retroauricular incision is closed. The tympano-meatal flap is replaced and a dressing is put into the EAC. Results - The new method has been applied thus far in 15 adults and pre-adolescent deaf patients (8 females, 7 males). A MED-EL Combi 40+ device was used in 14 patients and a Nucleus CI24M in 1. Pericanal electrode insertion was easy, with insertion depths into the cochlea of &;#83 30 mm with the MED-EL and of 20 mm with the Nucleus device. There were no surgical complications, infections or electrode extrusions during postoperative observation periods ranging from 6 months to >2 years. The functional results were comparable to those obtained with cochlear implantation via mastoidectomy. The pericanal electrode insertion technique has several advantages, the most important being that the danger of facial nerve damage is minimized and that the operating time is reduced by up to 50%. Conclusion - Cochlear implantation with pericanal electrode insertion is a simple, fast and particularly safe option which may replace the classical transmastoidal cochlear implantation method in adults and older children.     

人工耳蜗植入术中圆窗耳蜗电图评价耳蜗残余听功能

目的应用术中圆窗耳蜗电图评估极重度感音神经性聋患者耳蜗残余听功能。方法20例患者全麻下人工耳蜗植入手术过程中,行术中圆窗耳蜗电图测试,测出的复合动作电位（CAP）阈值与术前纯音测听或其他听力测试之阈值进行比较。结果20例患者术中圆窗耳蜗电图测试测出的复合动作电位（CAP）阈值与术前1、2、4kHz听力测试阈值分别有较好的相关系数（0．20429,0．04076,0．38163）。结论术中圆窗耳蜗电图可以较准确客观地评估极重度感音神经性聋患者耳蜗残余听功能,且是人工耳蜗植入术前听力学评估方法的有意义的补充。